Nexgel Inc Stock Price Patterns
| NXGL Stock | USD 1.36 0.06 4.23% |
Momentum 40
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.03) | EPS Estimate Current Year (0.28) | EPS Estimate Next Year 0.16 | Wall Street Target Price 6 | EPS Estimate Current Quarter (0.08) |
Using Nexgel hype-based prediction, you can estimate the value of Nexgel Inc from the perspective of Nexgel response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Nexgel to buy its stock at a price that has no basis in reality. In that case, they are not buying Nexgel because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nexgel after-hype prediction price | USD 1.37 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Nexgel Basic Forecasting Models to cross-verify your projections. Nexgel After-Hype Price Density Analysis
As far as predicting the price of Nexgel at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nexgel or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nexgel, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nexgel Estimiated After-Hype Price Volatility
In the context of predicting Nexgel's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nexgel's historical news coverage. Nexgel's after-hype downside and upside margins for the prediction period are 0.07 and 7.39, respectively. We have considered Nexgel's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nexgel is dangerous at this time. Analysis and calculation of next after-hype price of Nexgel Inc is based on 3 months time horizon.
Nexgel Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Nexgel is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nexgel backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nexgel, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.73 | 6.02 | 0.01 | 0.04 | 8 Events / Month | 5 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.36 | 1.37 | 0.74 |
|
Nexgel Hype Timeline
Nexgel Inc is now traded for 1.36. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.04. Nexgel is forecasted to increase in value after the next headline, with the price projected to jump to 1.37 or above. The average volatility of media hype impact on the company the price is over 100%. The price upswing on the next news is projected to be 0.74%, whereas the daily expected return is now at -0.73%. The volatility of related hype on Nexgel is about 10750.0%, with the expected price after the next announcement by competition of 1.32. The company reported the previous year's revenue of 8.69 M. Net Loss for the year was (3.28 M) with profit before overhead, payroll, taxes, and interest of 4.64 M. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Nexgel Basic Forecasting Models to cross-verify your projections.Nexgel Related Hype Analysis
Having access to credible news sources related to Nexgel's direct competition is more important than ever and may enhance your ability to predict Nexgel's future price movements. Getting to know how Nexgel's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nexgel may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RVP | Retractable Technologies | 0.01 | 7 per month | 0.00 | (0.20) | 2.63 | (3.57) | 10.11 | |
| HBIO | Harvard Bioscience | (0.01) | 8 per month | 4.98 | 0.07 | 12.86 | (6.78) | 57.46 | |
| FEMY | Femasys | (0.01) | 6 per month | 0.00 | (0.02) | 15.00 | (11.11) | 47.42 | |
| GDTC | CytoMed Therapeutics Limited | (0.30) | 9 per month | 0.00 | (0.28) | 6.03 | (10.38) | 31.46 | |
| NXL | Nexalin Technology | (0.06) | 9 per month | 0.00 | (0.25) | 7.92 | (8.70) | 27.45 | |
| ENLV | Enlivex Therapeutics | (0.12) | 7 per month | 4.29 | 0 | 8.57 | (8.16) | 24.21 | |
| MLSS | Milestone Scientific | 0.02 | 10 per month | 0.00 | (0.16) | 7.41 | (6.90) | 23.59 | |
| POCI | Precision Optics | 0.06 | 7 per month | 2.30 | 0.07 | 3.68 | (3.55) | 27.89 | |
| MTVA | MetaVia | (0.08) | 10 per month | 0.00 | (0.16) | 11.60 | (20.10) | 79.95 | |
| IINN | Inspira Technologies Oxy | (0.07) | 9 per month | 0.00 | (0.12) | 6.86 | (6.96) | 24.08 |
Nexgel Additional Predictive Modules
Most predictive techniques to examine Nexgel price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nexgel using various technical indicators. When you analyze Nexgel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nexgel Predictive Indicators
The successful prediction of Nexgel stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nexgel Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nexgel based on analysis of Nexgel hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nexgel's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nexgel's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 56.5 | 39.2 | 35.28 | 27.75 | PTB Ratio | 2.57 | 5.05 | 5.8 | 5.51 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Nexgel Basic Forecasting Models to cross-verify your projections. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. Anticipated expansion of Nexgel directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexgel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.40) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Investors evaluate Nexgel Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nexgel's intrinsic value—the estimated true worth—helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Nexgel's market price to deviate significantly from intrinsic value.
It's important to distinguish between Nexgel's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexgel should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nexgel's market price signifies the transaction level at which participants voluntarily complete trades.